In another 2006 clinical trial,(10)72 test subjects with pressure ulcers were presented with TB-500. The main aim of this randomized, double blind study was to establish the potential of thymosin beta 4 (analogous to TB-500) in ulcer presence
Your healthcare provider may consider your overall health, medical history, blood sugar levels, weight management goals, medication tolerance, and lifestyle habits before recommending a treatment option
This product is not classified as a drug, food, or cosmetic
Benefits: Promotes fat breakdown and metabolism
Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats
This strong antioxidant is well-known for making skin more radiant and improving overall health